Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals

• Hauptverfasser: Maria Rautamo (Verfasst von), Kirsi Kvarnström (Verfasst von), Mia Sivén (Verfasst von), Marja Airaksinen (Verfasst von), Pekka Lahdenne (Verfasst von), Niklas Sandler (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2020-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about futur...